BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 6, 2012
View Archived Issues
Allergan presents new S1P1 receptor ligands
Read More
Randomized trial shows benefit of armodafinil in patients with traumatic brain injury
Read More
Phase I/Ib trial evaluates AUY-922 alone and with bortezomib
Read More
Encouraging phase II results presented on PD-0332991
Read More
New LDL-PLA2 inhibitors developed by GlaxoSmithKline
Read More
Italian researchers disclose novel EP4 receptor antagonists
Read More
Roche divulges novel Mdm2/p53 interaction inhibitors
Read More
Chinese group reports new antivirals
Read More
U.S. university patents new polypeptides
Read More
Epizyme synthesizes novel DOT1-like protein inhibitors
Read More
Amitiza approved in Japan
Read More
Debio-0932 shows promising activity in patients with advanced solid tumors
Read More
Sirnaomics plans siRNA-based therapeutic study in China
Read More
Ultragenyx begins dosing in new UX-001 study
Read More
Pfizer grants ChemRar rights to DPP IV inhibitor
Read More
Prosonix and Imperial College London to collaborate on engineered combination respiratory medicines
Read More
FDA accepts Adasuve NDA resubmission
Read More
Optimer obtains approval in Canada for CDI treatment
Read More
Health Canada approves Jakavi for treatment of patients with myelofibrosis
Read More
New models of kidney cancer developed in U.S.
Read More
MK-6096 effective in multinational trial
Read More
Companies file application in Japan for oral imaging agent for malignant glioma
Read More
FDA approves first test for quantifying CMV DNA in human plasma
Read More
Amgen completes acquisition
Read More
New public-private partnership aims to develop pediatric formulation of schistosomiasis treatment
Read More